One of the following is required: (1) 120 credits including Biochemical Technology, 10 credits, or Methods in Biotechnology, 5 credits. 5 credits at Master's level in chemistry/pharmaceutical sciences/molecular biotechnology, or the course Experimental Methods in Structural Biology, 10 credits. Participation in Biologicals I, 7.5 credits; (2) 120 credits including Drug Development. Participation in Biologicals I, 7.5 credits; (3) Within the Master of Science Programme in Pharmacy, participation in all courses of semesters 1-7 and at least 150 credits in the programme including Pharmaceutical Biotechnology, as well as participation in Biologicals 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
In this course, we focus on engineering aspects of the development of biological drugs. The course combines lectures and seminars with theoretical and laboratory exercises. After an introduction to the design, structure and characteristics of different types of protein-based drugs, you will learn about strategies and methods of their production, how optimised variants can be designed, how their properties can be studied at different levels, and how their biological effects can be analysed. We will also discuss commercial and ethical aspects of the development and use of protein drugs.
